WHX Lagos and WHX Labs Lagos is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Informa
Vivek Kanade
Managing Director, Middle East & Africa at Siemens Healthineers
Automated Coagulation Analyzer - Shanghai Sun Biotech

Vivek Kanade is the Managing Director of Siemens Healthineers in the Middle East and Africa. In this role, Kanade is responsible for driving sustainable innovation and growth across the designated regional businesses of Siemens Healthineers. He joined from his prior role as Executive Director of Siemens Healthineers in India, Bangladesh, Nepal, Sri Lanka, Bhutan and the Maldives, followed by a six-month appointment as Head of Strategy for the company in Asia-Pacific, leading the regional strategic alignment and directions of the medical technology manufacturer. Kanade brings to the role 30 years of diverse experience in healthcare, leading high performing cross-functional teams across Europe, Asia and now the Middle East & Africa.

1. Briefly tell us about your organisation, the journey to date and your focus areas.*

Siemens Healthineers is active in the areas of diagnostic imaging, laboratory diagnostics, cancer care and minimally invasive therapies, leveraging the potential of digital technology and artificial intelligence. We channel our experience in and dedication to innovation to provide quality health care and increase access to care for everybody, especially the more vulnerable communities. Access to Care is one of our focal points in the Middle East & Africa region, supporting public and private organizations and our customers to build a sustainable and cost-efficient healthcare infrastructure, providing high quality healthcare where it is needed.

2. WHX Lagos is a one-stop destination for the region’s booming healthcare industry. Give us an insight into what your organisation is bringing to the show and the opportunities in the store for visitors to the event.*

As explained above, our focus is on building sustainable healthcare infrastructures and to expand equal access to care. Visitors to our booth will be able to learn more about how we contribute to these objectives and how local partnerships are leveraging our efforts in these areas. Of course, our experts are very much looking forward to guide conference attendees through our vast range of products and solutions, from diagnostic imaging, laboratory diagnostics, cancer care to minimally invasive therapies. And we are very keen to discuss how we can support healthcare providers along the entire continuum of care.

3. What are your organisational goals for 2025-2026? Please highlight some of your recent and upcoming partnerships, if any.*

In the Middle East and Africa, our focus as Siemens Healthineers will be on the development of healthcare infrastructures and the rising burden of non-communicable diseases such as cancer, diabetes, stroke etc., which is even more significant across regions with growing populations. Both public and private partnerships are of paramount importance to us to support in upgrading local healthcare infrastructure.

An example for one of our ground-breaking partnerships is a recently signed agreement with the Nigeria Sovereign Investment Authority and our colleagues from Varian, to establish seven oncology centres. A major milestone in expanding cancer care infrastructure!

Together with the African Medical Centre of Excellence in Abuja, we are taking a leap forward in access to care with the private sector, as Siemens Healthineers provides oncology and radiology equipment for a state-of-the-art hospital, enabling Nigerians to be treated in their own country, as opposed to having to travel abroad. “We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.”

Featured products
Below is a selection of products that our partners will be showcasing during Medlab Middle East 2025:Below is a selection of products that o